Navigation Links
Arete Therapeutics Initiates Phase IIa Clinical Trial for AR9281, a Novel s-EH Inhibitor to Treat Type 2 Diabetes
Date:2/10/2009

HAYWARD, Calif., Feb. 10 /PRNewswire/ -- Arete Therapeutics Inc. today announced the initiation of a Phase IIa clinical trial for AR9281, an orally- administered soluble epoxide hydrolase (s-EH) inhibitor being developed for the treatment of type 2 diabetes. S-EH is an enzyme involved in the metabolism of arachidonic acid, a key signaling molecule implicated in diabetes, hypertension and inflammatory disorders.

"Our AR9281 Phase II clinical trial program breaks new ground in two key areas. This is the first clinical study of a s-EH inhibitor in patients, and the first study designed to establish proof of concept that s-EH inhibition modulates glucose metabolism or blood pressure in patients with impaired glucose tolerance and hypertension," said James Sabry, M.D., Ph.D., President and Chief Executive Officer of Arete Therapeutics. "AR9281 has demonstrated an excellent safety profile and activity in multiple animal models of type 2 diabetes, and has the advantage of inhibiting a novel drug target that differentiates it from currently marketed diabetes medications. With this promising drug profile, AR9281 has the potential to provide safe and effective therapy for patients with type 2 diabetes either as monotherapy or in combination with existing treatment regimens."

The Phase IIa multicenter, double-blind, placebo-controlled study will enroll 150 pre-diabetic patients with impaired glucose tolerance, mild obesity and mild to moderate hypertension. All patients enrolled in the study will be treatment-naïve for type 2 diabetes medications. The trial will evaluate two schedules of AR9281 and placebo using a parallel design to determine the feasibility of twice-a-day dosing. Each patient will receive 28 days of treatment. Endpoints for the trial include safety, tolerability, reduction of blood pressure and various measures of glucose and lipid metabolism, with results expected in the first quarter of 2010.'/>"/>

SOURCE Arete Therapeutics Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. CareTech Solutions Executive to Conduct Presentation on Creating a Healthy Revenue Cycle at AHIMA Convention and Exhibit
2. Arete Therapeutics Initiates Phase 1 Clinical Trial For AR9281 as a First-in-Class Antihypertensive Agent
3. Arete Therapeutics Appoints Donald Santel to Board of Directors
4. CareTech Solutions Service Desk Equals Help Desk Plus
5. Nationally Recognized Diabetes Specialist Dr. Steven Edelman to Provide Educational Articles on Diabetes to MyCareTeam's Website Community
6. CareTech Solutions Named Best in KLAS for Extensive IT Outsourcing Services
7. EnovateIT Partners with CareTech Solutions to Create a Custom Product for Crittenton Hospital Medical Center, One of the Nation's Most Wired Hospitals
8. Prime Therapeutics Receives TIPPS Certification
9. Adams Respiratory Therapeutics to Celebrate 10th Anniversary of its Incorporation on September 12
10. Transition Therapeutics Announces Fiscal 2007 Year End Financial Results
11. Lorus Therapeutics announces election of three new Directors and appoints a new Chairman
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2014)... November 26, 2014 The Maryland ... for the tenth annual MEDA Awards, which, sponsored ... excellence in Maryland. “The MEDA Awards recognize the ... to the state. We encourage our members to ... making a positive economic impact in the state ...
(Date:11/26/2014)... The American Anthropological Association (AAA) has ... of meetings and conferences. Suvarnakar will be responsible ... and conferences. , “I am pleased to ... Executive Director Ed Liebow. “She brings the Association ... was recognized in January as the 2013 Professional ...
(Date:11/26/2014)... Loffler Companies has been selected as ... an online information and news publication for resellers of ... consecutive year Loffler has earned this prestigious award and ... Dealer Awards honor the best and the brightest in ... honorees were chosen for their innovative marketing and sales ...
(Date:11/26/2014)... Sonru, the video interviewing specialist, has today announced the ... Marketing Officer, in addition to the formal opening of ... been appointed as Chief Operating Officer. He is joined ... Marketing Officer. , Mr Jones is a seasoned tech, ... roles with The Walt Disney Company and Adventis where ...
(Date:11/26/2014)... Bunion Bootie, the newest and best ... early celebration of the early holiday shopping season. Starting ... the promotional price of $29.95 each (normally $33.95 ea). ... any automatic discounts applied when buying more than one ... for complete details. It’s simple: purchasing more Bunion Booties ...
Breaking Medicine News(10 mins):Health News:Maryland Economic Development Association Seeking Submissions for 2015 Awards 2Health News:American Anthropological Association Appoints New Director of Meetings and Conferences: Ushma Suvarnakar 2Health News:Loffler Companies Recognized as an Elite Dealer for Sixth Consecutive Year 2Health News:Sonru Expansion continues with appointment of new executive team and opening of new London base 2Health News:Bunion Bootie Temporarily Lowering Prices for Holiday Shopping, Starting Today! 2
... Kolkata's B.M. Birla Heart Research Centre Friday became the first ... recognition of its high quality patient care. ,The ... certification "is an endorsement of our focus on quality", Suyash ... ,"The NABH tag will be a tool to win over ...
... of enzymes called sirtuins, which can dramatically extend life ... ,Now, a new study from scientists at ... sirtuins to unleash their anti-aging powers. They may also ... and type II diabetes. ,Naturally occurring substances ...
... drugs like marijuana is not easy as it results in ... life the usage started. ,Marijuana, a mixture of ... sativa, is smoked as a cigarette or in a pipe. ... ,A study called "Monitoring the Future," conducted by ...
... It’s a gift that brought tears to the receiver and ... million dollars was pledged to the staff at Toronto’s Hospital for ... a scion of a beer baron and well-established friend of the ... Investment Management mutual fund company and his wife Sonia, have pledged ...
... study the significance of thyroid checkup in pregnant women to ... check up should be made mandatory in pregnant women, even ... have shown that even a slightly under active or a ... or miscarriage or babies with lower IQ's. ,2-5 ...
... RSRF announced the results of a landmark study reversing ... mouse model//. The findings, by Adrian Bird, Ph.D., of ... Syndrome Research Foundation (RSRF) Scientific Advisory Board, appear online ... ,Rett Syndrome is a severe childhood neurological disease ...
Cached Medicine News:Health News:Anti-Aging Powers of Enzyme Sirtuins 2Health News:Record Donation to Children’s Hospita 2Health News:Pregnant? Check Your Thyroid Secretion! 2Health News:Rett Syndrome Reversed in Genetic Mouse Model 2Health News:Rett Syndrome Reversed in Genetic Mouse Model 3
(Date:11/26/2014)... 25, 2014 Nanomix Inc., (Nanomix), ... development of mobile diagnostic tests to enable ... and pre-hospital settings, today announced it has ... The certification was awarded by the British ... leading certification bodies. ISO ...
(Date:11/26/2014)... 25, 2014  Array BioPharma Inc. (Nasdaq: ... its Chief Executive Officer, Ron Squarer ... conferences.  The public is welcome to participate ... Array BioPharma website:  www.arraybiopharma.com .Event: Piper Jaffray ...  Eastern Time Location: Palace Hotel, New York ...
(Date:11/26/2014)... , Nov. 25, 2014 Jazz Pharmaceuticals plc (Nasdaq: ... webcasting its corporate presentations at two upcoming investor conferences.  ... London, UK on Tuesday, December 2, 2014 at 6:45 ... vice president and head of EUSA International, will provide an overview ... 26 th Annual Piper Jaffray Healthcare Conference in ...
Breaking Medicine Technology:Nanomix Receives ISO 13485:2003 Certification 2Jazz Pharmaceuticals Announces Participation in Two Investor Conferences 2
... 31 Greenway Medical Technologies, Inc. today announced ... (HIE) programs, Independent Physician Associations (IPA) and regional ... company,s integrated electronic health record (EHR) practice management ... streamline clinical, financial and administrative functions. ...
... Corporation, a spinal and orthopaedic implant and instrument ... technologies, announced today that it has been granted ... improved knee implant prosthesis that features a monoblock ... prosthetic (resurfaced) femoral surfaces.  This is an important ...
Cached Medicine Technology:Greenway Selected by Health Information Exchanges and Regional Physician Groups 2Greenway Selected by Health Information Exchanges and Regional Physician Groups 3Greenway Selected by Health Information Exchanges and Regional Physician Groups 4Amedica® Receives Patent for Knee Prosthesis With Monoblock Silicon Nitride Ceramic Tibial Component 2Amedica® Receives Patent for Knee Prosthesis With Monoblock Silicon Nitride Ceramic Tibial Component 3
The IDS Gamma-B 25-Hydroxy Vitamin D kit is a conventional liquid phase radioimmunoassay intended for the quantitative determination of 25-hydroxy vitamin D (25-OHD) and other hydroxylated metabolite...
... This is the comprehensive, simple and ... has a compact, bench-top design, but ... previously only found in high-volume systems. ... cost-effective solution and can also be ...
A complete workstation for haemostasis , A compact and convenient analyser , A comprehensive system , An exellent reliability: the STAGO patented detection mode...
... a fully automated open random access ... immunological, latex based coagulation tests. The ... racks as sample carrier offers 220 ... to 70 reagents on-board with the ...
Medicine Products: